Quest Pharmatech Stock Probability of Future Pink Sheet Price Finishing Over 0.0133
| QPTFF Stock | USD 0.01 0.00 0.00% |
Quest |
Quest PharmaTech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Quest PharmaTech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Quest PharmaTech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Quest PharmaTech generated a negative expected return over the last 90 days | |
| Quest PharmaTech has some characteristics of a very speculative penny stock | |
| Quest PharmaTech has accumulated 1000 K in total debt with debt to equity ratio (D/E) of 0.01, which may suggest the company is not taking enough advantage from borrowing. Quest PharmaTech has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Quest PharmaTech until it has trouble settling it off, either with new capital or with free cash flow. So, Quest PharmaTech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Quest PharmaTech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Quest to invest in growth at high rates of return. When we think about Quest PharmaTech's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (85.04 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Quest PharmaTech has accumulated about 518.76 K in cash with (170.78 K) of positive cash flow from operations. | |
| Roughly 17.0% of Quest PharmaTech outstanding shares are owned by corporate insiders |
Quest PharmaTech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Quest Pink Sheet often depends not only on the future outlook of the current and potential Quest PharmaTech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Quest PharmaTech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 168.2 M |
Quest PharmaTech Technical Analysis
Quest PharmaTech's future price can be derived by breaking down and analyzing its technical indicators over time. Quest Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Quest PharmaTech. In general, you should focus on analyzing Quest Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Quest PharmaTech Predictive Forecast Models
Quest PharmaTech's time-series forecasting models is one of many Quest PharmaTech's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Quest PharmaTech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Quest PharmaTech
Checking the ongoing alerts about Quest PharmaTech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Quest PharmaTech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Quest PharmaTech generated a negative expected return over the last 90 days | |
| Quest PharmaTech has some characteristics of a very speculative penny stock | |
| Quest PharmaTech has accumulated 1000 K in total debt with debt to equity ratio (D/E) of 0.01, which may suggest the company is not taking enough advantage from borrowing. Quest PharmaTech has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Quest PharmaTech until it has trouble settling it off, either with new capital or with free cash flow. So, Quest PharmaTech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Quest PharmaTech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Quest to invest in growth at high rates of return. When we think about Quest PharmaTech's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (85.04 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Quest PharmaTech has accumulated about 518.76 K in cash with (170.78 K) of positive cash flow from operations. | |
| Roughly 17.0% of Quest PharmaTech outstanding shares are owned by corporate insiders |
Other Information on Investing in Quest Pink Sheet
Quest PharmaTech financial ratios help investors to determine whether Quest Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Quest with respect to the benefits of owning Quest PharmaTech security.